Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1996 Oct;104(Suppl 5):883–893. doi: 10.1289/ehp.96104s5883

Human DNA adduct measurements: state of the art.

M C Poirier 1, A Weston 1
PMCID: PMC1469680  PMID: 8933030

Abstract

Human DNA adduct formation (covalent modification of DNA with chemical carcinogens) is a promising biomarker for elucidating the molecular epidemiology of cancer. Classes of compounds for which human DNA adducts have been observed include polycyclic aromatic hydrocarbons (PAHs), nitrosamines, mycotoxins, aromatic amines, heterocyclic amines, ultraviolet light, and alkylating cancer chemotherapeutic agents. Most human DNA adduct exposure monitoring has been performed with either 32P-postlabeling or immunoassays, neither of which is able to chemically characterize specific DNA adducts. Recently developed combinations of methods with chemical and physical end points have allowed identification of specific adducts in human tissues. Studies are presented that demonstrate that high ambient levels of benzo[a]pyrene are associated with high levels of DNA adducts in human blood cell DNA and that the same DNA adduct levels drop when the ambient PAH levels decrease significantly. DNA adduct dosimetry, which has been achieved with some dietary carcinogens and cancer chemotherapeutic agents, is described, as well as studies correlating DNA adducts with other biomarkers. It is likely that some toxic, noncarcinogenic compounds may have genotoxic effects, including oxidative damage, and that adverse health outcomes other than cancer may be correlated with DNA adduct formation. The studies presented here may serve as useful prototypes for exploration of other toxicological end points.

Full text

PDF
883

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexandrov K., Rojas M., Geneste O., Castegnaro M., Camus A. M., Petruzzelli S., Giuntini C., Bartsch H. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 1992 Nov 15;52(22):6248–6253. [PubMed] [Google Scholar]
  2. Beach A. C., Gupta R. C. Human biomonitoring and the 32P-postlabeling assay. Carcinogenesis. 1992 Jul;13(7):1053–1074. doi: 10.1093/carcin/13.7.1053. [DOI] [PubMed] [Google Scholar]
  3. Bianchini F., Montesano R., Shuker D. E., Cuzick J., Wild C. P. Quantification of 7-methyldeoxyguanosine using immunoaffinity purification and HPLC with electrochemical detection. Carcinogenesis. 1993 Aug;14(8):1677–1682. doi: 10.1093/carcin/14.8.1677. [DOI] [PubMed] [Google Scholar]
  4. Bodell W. J., Pongracz K., Kaur S., Burlingame A. L., Liu S. F., Rappaport S. M. Investigation of styrene oxide-DNA adducts and their detection in workers exposed to styrene. Prog Clin Biol Res. 1990;340C:271–282. [PubMed] [Google Scholar]
  5. Bruze M., Emmett E. A., Creasey J., Strickland P. T. Cyclobuta-dithymidine induction by solar-simulating UV radiation in human skin: II. Individual responses. J Invest Dermatol. 1989 Sep;93(3):341–344. [PubMed] [Google Scholar]
  6. Bryant M. S., Skipper P. L., Tannenbaum S. R., Maclure M. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 1987 Jan 15;47(2):602–608. [PubMed] [Google Scholar]
  7. Bryant M. S., Vineis P., Skipper P. L., Tannenbaum S. R. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9788–9791. doi: 10.1073/pnas.85.24.9788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chaudhary A. K., Nokubo M., Reddy G. R., Yeola S. N., Morrow J. D., Blair I. A., Marnett L. J. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science. 1994 Sep 9;265(5178):1580–1582. doi: 10.1126/science.8079172. [DOI] [PubMed] [Google Scholar]
  9. Cooper D. P., Griffin K. A., Povey A. C. Immunoaffinity purification combined with 32P-postlabelling for the detection of O6-methylguanine in DNA from human tissues. Carcinogenesis. 1992 Mar;13(3):469–475. doi: 10.1093/carcin/13.3.469. [DOI] [PubMed] [Google Scholar]
  10. Corley J., Hurtubise R. J., Bowman E. D., Weston A. Solid matrix, room temperature phosphorescence identification and quantitation of the tetrahydrotetrols derived from the acid hydrolysis of benzo[a]pyrene-DNA adducts from human lung. Carcinogenesis. 1995 Feb;16(2):423–426. doi: 10.1093/carcin/16.2.423. [DOI] [PubMed] [Google Scholar]
  11. Cuzick J., Routledge M. N., Jenkins D., Garner R. C. DNA adducts in different tissues of smokers and non-smokers. Int J Cancer. 1990 Apr 15;45(4):673–678. doi: 10.1002/ijc.2910450417. [DOI] [PubMed] [Google Scholar]
  12. Day B. W., Naylor S., Gan L. S., Sahali Y., Nguyen T. T., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts. Cancer Res. 1990 Aug 1;50(15):4611–4618. [PubMed] [Google Scholar]
  13. Degan P., Shigenaga M. K., Park E. M., Alperin P. E., Ames B. N. Immunoaffinity isolation of urinary 8-hydroxy-2'-deoxyguanosine and 8-hydroxyguanine and quantitation of 8-hydroxy-2'-deoxyguanosine in DNA by polyclonal antibodies. Carcinogenesis. 1991 May;12(5):865–871. doi: 10.1093/carcin/12.5.865. [DOI] [PubMed] [Google Scholar]
  14. Farmer P. B., Bailey E., Green J. A., Leung C. S., Manson M. M. Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA. IARC Sci Publ. 1991;(105):71–77. [PubMed] [Google Scholar]
  15. Farmer P. B., Shuker E. G., Bird I. DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs. Carcinogenesis. 1986 Jan;7(1):49–52. doi: 10.1093/carcin/7.1.49. [DOI] [PubMed] [Google Scholar]
  16. Ferreira Júnior M. F., Tas S., dell'Omo M., Goormans G., Buchet J. P., Lauwerys R. Determinants of benzo(a)pyrenediol epoxide adducts to haemoglobin in workers exposed to polycyclic aromatic hydrocarbons. Occup Environ Med. 1994 Jul;51(7):451–455. doi: 10.1136/oem.51.7.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fichtinger-Schepman A. M., van Oosterom A. T., Lohman P. H., Berends F. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res. 1987 Jun 1;47(11):3000–3004. [PubMed] [Google Scholar]
  18. Fichtinger-Schepman A. M., van der Velde-Visser S. D., van Dijk-Knijnenburg H. C., van Oosterom A. T., Baan R. A., Berends F. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation. Cancer Res. 1990 Dec 15;50(24):7887–7894. [PubMed] [Google Scholar]
  19. Floyd R. A., Watson J. J., Wong P. K., Altmiller D. H., Rickard R. C. Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Radic Res Commun. 1986;1(3):163–172. doi: 10.3109/10715768609083148. [DOI] [PubMed] [Google Scholar]
  20. Foiles P. G., Akerkar S. A., Carmella S. G., Kagan M., Stoner G. D., Resau J. H., Hecht S. S. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem Res Toxicol. 1991 May-Jun;4(3):364–368. doi: 10.1021/tx00021a017. [DOI] [PubMed] [Google Scholar]
  21. Friesen M. D., Kaderlik K., Lin D., Garren L., Bartsch H., Lang N. P., Kadlubar F. F. Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: validation by comparison with 32P-postlabeling. Chem Res Toxicol. 1994 Nov-Dec;7(6):733–739. doi: 10.1021/tx00042a004. [DOI] [PubMed] [Google Scholar]
  22. Geneste O., Camus A. M., Castegnaro M., Petruzzelli S., Macchiarini P., Angeletti C. A., Giuntini C., Bartsch H. Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis. 1991 Jul;12(7):1301–1305. doi: 10.1093/carcin/12.7.1301. [DOI] [PubMed] [Google Scholar]
  23. Gorelick N. J. Application of HPLC in the 32P-postlabeling assay. Mutat Res. 1993 Jul;288(1):5–18. doi: 10.1016/0027-5107(93)90203-r. [DOI] [PubMed] [Google Scholar]
  24. Groopman J. D., Donahue P. R., Zhu J. Q., Chen J. S., Wogan G. N. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6492–6496. doi: 10.1073/pnas.82.19.6492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Groopman J. D., Hall A. J., Whittle H., Hudson G. J., Wogan G. N., Montesano R., Wild C. P. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev. 1992 Mar-Apr;1(3):221–227. [PubMed] [Google Scholar]
  26. Groopman J. D., Hasler J. A., Trudel L. J., Pikul A., Donahue P. R., Wogan G. N. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography. Cancer Res. 1992 Jan 15;52(2):267–274. [PubMed] [Google Scholar]
  27. Groopman J. D., Trudel L. J., Donahue P. R., Marshak-Rothstein A., Wogan G. N. High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7728–7731. doi: 10.1073/pnas.81.24.7728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Groopman J. D., Zhu J. Q., Donahue P. R., Pikul A., Zhang L. S., Chen J. S., Wogan G. N. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res. 1992 Jan 1;52(1):45–52. [PubMed] [Google Scholar]
  29. Grzybowska E., Hemminki K., Szeliga J., Chorazy M. Seasonal variation of aromatic DNA adducts in human lymphocytes and granulocytes. Carcinogenesis. 1993 Dec;14(12):2523–2526. doi: 10.1093/carcin/14.12.2523. [DOI] [PubMed] [Google Scholar]
  30. Harris C. C., LaVeck G., Groopman J., Wilson V. L., Mann D. Measurement of aflatoxin B1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry. Cancer Res. 1986 Jul;46(7):3249–3253. [PubMed] [Google Scholar]
  31. Harris C. C., Vahakangas K., Newman M. J., Trivers G. E., Shamsuddin A., Sinopoli N., Mann D. L., Wright W. E. Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6672–6676. doi: 10.1073/pnas.82.19.6672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Haugen A., Becher G., Benestad C., Vahakangas K., Trivers G. E., Newman M. J., Harris C. C. Determination of polycyclic aromatic hydrocarbons in the urine, benzo(a)pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res. 1986 Aug;46(8):4178–4183. [PubMed] [Google Scholar]
  33. Hemminki K., Grzybowska E., Chorazy M., Twardowska-Saucha K., Sroczynski J. W., Putman K. L., Randerath K., Phillips D. H., Hewer A., Santella R. M. DNA adducts in human environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis. 1990 Jul;11(7):1229–1231. doi: 10.1093/carcin/11.7.1229. [DOI] [PubMed] [Google Scholar]
  34. Hemminki K., Perera F. P., Phillips D. H., Randerath K., Reddy M. V., Santella R. M. Aromatic DNA adducts in white blood cells of foundry workers. IARC Sci Publ. 1988;(89):190–195. [PubMed] [Google Scholar]
  35. Hemminki K., Perera F. P., Phillips D. H., Randerath K., Reddy M. V., Santella R. M. Aromatic deoxyribonucleic acid adducts in white blood cells of foundry and coke oven workers. Scand J Work Environ Health. 1988;14 (Suppl 1):55–56. [PubMed] [Google Scholar]
  36. Hemminki K., Randerath K., Reddy M. V., Putman K. L., Santella R. M., Perera F. P., Young T. L., Phillips D. H., Hewer A., Savela K. Postlabeling and immunoassay analysis of polycyclic aromatic hydrocarbons--adducts of deoxyribonucleic acid in white blood cells of foundry workers. Scand J Work Environ Health. 1990 Jun;16(3):158–162. doi: 10.5271/sjweh.1798. [DOI] [PubMed] [Google Scholar]
  37. Herron D. C., Shank R. C. Methylated purines in human liver DNA after probable dimethylnitrosamine poisoning. Cancer Res. 1980 Sep;40(9):3116–3117. [PubMed] [Google Scholar]
  38. Holz O., Krause T., Scherer G., Schmidt-Preuss U., Rüdiger H. W. 32P-postlabelling analysis of DNA adducts in monocytes of smokers and passive smokers. Int Arch Occup Environ Health. 1990;62(4):299–303. doi: 10.1007/BF00640837. [DOI] [PubMed] [Google Scholar]
  39. Horvath E., Pongracz K., Rappaport S., Bodell W. J. 32P-post-labeling detection of DNA adducts in mononuclear cells of workers occupationally exposed to styrene. Carcinogenesis. 1994 Jul;15(7):1309–1315. doi: 10.1093/carcin/15.7.1309. [DOI] [PubMed] [Google Scholar]
  40. Hsieh L. L., Hsu S. W., Chen D. S., Santella R. M. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Cancer Res. 1988 Nov 15;48(22):6328–6331. [PubMed] [Google Scholar]
  41. Huh N. H., Satoh M. S., Shiga J., Rajewsky M. F., Kuroki T. Immunoanalytical detection of O4-ethylthymine in liver DNA of individuals with or without malignant tumors. Cancer Res. 1989 Jan 1;49(1):93–97. [PubMed] [Google Scholar]
  42. Ichiba M., Hagmar L., Rannug A., Högstedt B., Alexandrie A. K., Carstensen U., Hemminki K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis. 1994 Jul;15(7):1347–1352. doi: 10.1093/carcin/15.7.1347. [DOI] [PubMed] [Google Scholar]
  43. Jahnke G. D., Thompson C. L., Walker M. P., Gallagher J. E., Lucier G. W., DiAugustine R. P. Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis. Carcinogenesis. 1990 Feb;11(2):205–211. doi: 10.1093/carcin/11.2.205. [DOI] [PubMed] [Google Scholar]
  44. Jones N. J., McGregor A. D., Waters R. Detection of DNA adducts in human oral tissue: correlation of adduct levels with tobacco smoking and differential enhancement of adducts using the butanol extraction and nuclease P1 versions of 32P postlabeling. Cancer Res. 1993 Apr 1;53(7):1522–1528. [PubMed] [Google Scholar]
  45. Jongeneelen F. J. Biological monitoring of environmental exposure to polycyclic aromatic hydrocarbons; 1-hydroxypyrene in urine of people. Toxicol Lett. 1994 Jun;72(1-3):205–211. doi: 10.1016/0378-4274(94)90030-2. [DOI] [PubMed] [Google Scholar]
  46. Kaderlik K. R., Talaska G., DeBord D. G., Osorio A. M., Kadlubar F. F. 4,4'-Methylene-bis(2-chloroaniline)-DNA adduct analysis in human exfoliated urothelial cells by 32P-postlabeling. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):63–69. [PubMed] [Google Scholar]
  47. Kang H. I., Konishi C., Eberle G., Rajewsky M. F., Kuroki T., Huh N. H. Highly sensitive, specific detection of O6-methylguanine, O4-methylthymine, and O4-ethylthymine by the combination of high-performance liquid chromatography prefractionation, 32P postlabeling, and immunoprecipitation. Cancer Res. 1992 Oct 1;52(19):5307–5312. [PubMed] [Google Scholar]
  48. Kasai H., Crain P. F., Kuchino Y., Nishimura S., Ootsuyama A., Tanooka H. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis. 1986 Nov;7(11):1849–1851. doi: 10.1093/carcin/7.11.1849. [DOI] [PubMed] [Google Scholar]
  49. Kato S., Petruzzelli S., Bowman E. D., Turteltaub K. W., Blomeke B., Weston A., Shields P. G. 7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay. Carcinogenesis. 1993 Apr;14(4):545–550. doi: 10.1093/carcin/14.4.545. [DOI] [PubMed] [Google Scholar]
  50. Kato S., Yamashita K., Kim T., Tajiri T., Onda M., Sato S. Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis. Mutat Res. 1988 Nov;202(1):85–91. doi: 10.1016/0027-5107(88)90167-4. [DOI] [PubMed] [Google Scholar]
  51. Kiyosawa H., Suko M., Okudaira H., Murata K., Miyamoto T., Chung M. H., Kasai H., Nishimura S. Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes. Free Radic Res Commun. 1990;11(1-3):23–27. doi: 10.3109/10715769009109664. [DOI] [PubMed] [Google Scholar]
  52. Kyrtopoulos S. A., Ampatzi P., Davaris P., Haritopoulos N., Golematis B. Studies in gastric carcinogenesis. IV. O6-methylguanine and its repair in normal and atrophic biopsy specimens of human gastric mucosa. Correlation of O6-alkylguanine-DNA alkyltransferase activities in gastric mucosa and circulating lymphocytes. Carcinogenesis. 1990 Mar;11(3):431–436. doi: 10.1093/carcin/11.3.431. [DOI] [PubMed] [Google Scholar]
  53. Kyrtopoulos S. A., Souliotis V. L., Valavanis C., Boussiotis V. A., Pangalis G. A. Accumulation of O6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects. Environ Health Perspect. 1993 Mar;99:143–147. doi: 10.1289/ehp.9399143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Lee H. S., Sarosi I., Vyas G. N. Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology. 1989 Nov;97(5):1281–1287. doi: 10.1016/0016-5085(89)91700-9. [DOI] [PubMed] [Google Scholar]
  55. Leng M., Sage E., Fuchs R. P., Duane M. P. Antibodies to DNA modified by the carcinogen N-acetoxy-N-2-acetylaminofluorene. FEBS Lett. 1978 Aug 15;92(2):207–210. doi: 10.1016/0014-5793(78)80755-8. [DOI] [PubMed] [Google Scholar]
  56. Lewtas J., Mumford J., Everson R. B., Hulka B., Wilcosky T., Kozumbo W., Thompson C., George M., Dobiás L., Srám R. Comparison of DNA adducts from exposure to complex mixtures in various human tissues and experimental systems. Environ Health Perspect. 1993 Mar;99:89–97. doi: 10.1289/ehp.939989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Lin D., Lay J. O., Jr, Bryant M. S., Malaveille C., Friesen M., Bartsch H., Lang N. P., Kadlubar F. F. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ Health Perspect. 1994 Oct;102 (Suppl 6):11–16. doi: 10.1289/ehp.94102s611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Manchester D. K., Weston A., Choi J. S., Trivers G. E., Fennessey P. V., Quintana E., Farmer P. B., Mann D. L., Harris C. C. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9243–9247. doi: 10.1073/pnas.85.23.9243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Manchester D. K., Wilson V. L., Hsu I. C., Choi J. S., Parker N. B., Mann D. L., Weston A., Harris C. C. Synchronous fluorescence spectroscopic, immunoaffinity chromatographic and 32P-postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts. Carcinogenesis. 1990 Apr;11(4):553–559. doi: 10.1093/carcin/11.4.553. [DOI] [PubMed] [Google Scholar]
  60. Mumford J. L., Lee X., Lewtas J., Young T. L., Santella R. M. DNA adducts as biomarkers for assessing exposure to polycyclic aromatic hydrocarbons in tissues from Xuan Wei women with high exposure to coal combustion emissions and high lung cancer mortality. Environ Health Perspect. 1993 Mar;99:83–87. doi: 10.1289/ehp.939983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Möller L., Zeisig M., Vodicka P. Optimization of an HPLC method for analyses of 32P-postlabeled DNA adducts. Carcinogenesis. 1993 Jul;14(7):1343–1348. doi: 10.1093/carcin/14.7.1343. [DOI] [PubMed] [Google Scholar]
  62. Müller R., Rajewsky M. F. Sensitive radioimmunoassay for detection of O6-ethyldeoxyguanosine in DNA exposed to the carcinogen ethylnitrosourea in vivo or in vitro. Z Naturforsch C. 1978 Nov-Dec;33(11-12):897–901. doi: 10.1515/znc-1978-11-1216. [DOI] [PubMed] [Google Scholar]
  63. Perera F. P., Dickey C., Santella R., O'Neill J. P., Albertini R. J., Ottman R., Tsai W. Y., Mooney L. A., Savela K., Hemminki K. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis. 1994 Dec;15(12):2905–2910. doi: 10.1093/carcin/15.12.2905. [DOI] [PubMed] [Google Scholar]
  64. Perera F. P., Hemminki K., Gryzbowska E., Motykiewicz G., Michalska J., Santella R. M., Young T. L., Dickey C., Brandt-Rauf P., De Vivo I. Molecular and genetic damage in humans from environmental pollution in Poland. Nature. 1992 Nov 19;360(6401):256–258. doi: 10.1038/360256a0. [DOI] [PubMed] [Google Scholar]
  65. Perera F. P., Hemminki K., Young T. L., Brenner D., Kelly G., Santella R. M. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res. 1988 Apr 15;48(8):2288–2291. [PubMed] [Google Scholar]
  66. Perera F. P., Tang D. L., O'Neill J. P., Bigbee W. L., Albertini R. J., Santella R., Ottman R., Tsai W. Y., Dickey C., Mooney L. A. HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts. Carcinogenesis. 1993 May;14(5):969–973. doi: 10.1093/carcin/14.5.969. [DOI] [PubMed] [Google Scholar]
  67. Pfohl-Leszkowicz A., Grosse Y., Castegnaro M., Nicolov I. G., Chernozemsky I. N., Bartsch H., Betbeder A. M., Creppy E. E., Dirheimer G. Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. IARC Sci Publ. 1993;(124):141–148. [PubMed] [Google Scholar]
  68. Phillips D. H., Hewer A., Grover P. L. Aromatic DNA adducts in human bone marrow and peripheral blood leukocytes. Carcinogenesis. 1986 Dec;7(12):2071–2075. doi: 10.1093/carcin/7.12.2071. [DOI] [PubMed] [Google Scholar]
  69. Phillips D. H., Hewer A., Grover P. L., Jass J. R. An aromatic DNA adduct in colonic mucosa from patients with colorectal cancer. IARC Sci Publ. 1988;(89):368–371. [PubMed] [Google Scholar]
  70. Plooy A. C., Fichtinger-Schepman A. M., Schutte H. H., van Dijk M., Lohman P. H. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques. Carcinogenesis. 1985 Apr;6(4):561–566. doi: 10.1093/carcin/6.4.561. [DOI] [PubMed] [Google Scholar]
  71. Poirier M. C. Antibodies to carcinogen-DNA adducts. J Natl Cancer Inst. 1981 Sep;67(3):515–519. [PubMed] [Google Scholar]
  72. Poirier M. C., Beland F. A. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. Chem Res Toxicol. 1992 Nov-Dec;5(6):749–755. doi: 10.1021/tx00030a003. [DOI] [PubMed] [Google Scholar]
  73. Poirier M. C., Reed E., Litterst C. L., Katz D., Gupta-Burt S. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients. Cancer Res. 1992 Jan 1;52(1):149–153. [PubMed] [Google Scholar]
  74. Poirier M. C., Reed E., Zwelling L. A., Ozols R. F., Litterst C. L., Yuspa S. H. Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models. Environ Health Perspect. 1985 Oct;62:89–94. doi: 10.1289/ehp.856289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Poirier M. C., Santella R., Weinstein I. B., Grunberger D., Yuspa S. H. Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res. 1980 Feb;40(2):412–416. [PubMed] [Google Scholar]
  76. Poirier M. C. The use of carcinogen-DNA adduct antisera for quantitation and localization of genomic damage in animal models and the human population. Environ Mutagen. 1984;6(6):879–887. doi: 10.1002/em.2860060615. [DOI] [PubMed] [Google Scholar]
  77. Poirier M. C., Weston A. DNA adduct determination in humans. Prog Clin Biol Res. 1991;372:205–218. [PubMed] [Google Scholar]
  78. Poirier M. C., Yuspa S. H., Weinstein I. B., Blobstein S. Detection of carcinogen-DNA adducts by radiommunoassay. Nature. 1977 Nov 10;270(5633):186–188. doi: 10.1038/270186a0. [DOI] [PubMed] [Google Scholar]
  79. Prevost V., Shuker D. E., Friesen M. D., Eberle G., Rajewsky M. F., Bartsch H. Immunoaffinity purification and gas chromatography-mass spectrometric quantification of 3-alkyladenines in urine: metabolism studies and basal excretion levels in man. Carcinogenesis. 1993 Feb;14(2):199–204. doi: 10.1093/carcin/14.2.199. [DOI] [PubMed] [Google Scholar]
  80. Randerath K., Miller R. H., Mittal D., Randerath E. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: application to unidentified genotoxicants. IARC Sci Publ. 1988;(89):361–367. [PubMed] [Google Scholar]
  81. Reddy M. V., Randerath K. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis. 1986 Sep;7(9):1543–1551. doi: 10.1093/carcin/7.9.1543. [DOI] [PubMed] [Google Scholar]
  82. Reed E., Gupta-Burt S., Litterst C. L., Poirier M. C. Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA. Carcinogenesis. 1990 Dec;11(12):2117–2121. doi: 10.1093/carcin/11.12.2117. [DOI] [PubMed] [Google Scholar]
  83. Reed E., Ozols R. F., Tarone R., Yuspa S. H., Poirier M. C. The measurement of cisplatin-DNA adduct levels in testicular cancer patients. Carcinogenesis. 1988 Oct;9(10):1909–1911. doi: 10.1093/carcin/9.10.1909. [DOI] [PubMed] [Google Scholar]
  84. Reed E., Parker R. J., Gill I., Bicher A., Dabholkar M., Vionnet J. A., Bostick-Bruton F., Tarone R., Muggia F. M. Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies. Cancer Res. 1993 Aug 15;53(16):3694–3699. [PubMed] [Google Scholar]
  85. Reed E., Yuspa S. H., Zwelling L. A., Ozols R. F., Poirier M. C. Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J Clin Invest. 1986 Feb;77(2):545–550. doi: 10.1172/JCI112335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Roberts D. W., Benson R. W., Groopman J. D., Flammang T. J., Nagle W. A., Moss A. J., Kadlubar F. F. Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl. Cancer Res. 1988 Nov 15;48(22):6336–6342. [PubMed] [Google Scholar]
  87. Rothman N., Correa-Villaseñor A., Ford D. P., Poirier M. C., Haas R., Hansen J. A., O'Toole T., Strickland P. T. Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):341–347. [PubMed] [Google Scholar]
  88. Rothman N., Poirier M. C., Baser M. E., Hansen J. A., Gentile C., Bowman E. D., Strickland P. T. Formation of polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells during consumption of charcoal-broiled beef. Carcinogenesis. 1990 Jul;11(7):1241–1243. doi: 10.1093/carcin/11.7.1241. [DOI] [PubMed] [Google Scholar]
  89. Rothman N., Shields P. G., Poirier M. C., Harrington A. M., Ford D. P., Strickland P. T. The impact of glutathione s-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol Carcinog. 1995 Sep;14(1):63–68. doi: 10.1002/mc.2940140111. [DOI] [PubMed] [Google Scholar]
  90. Roza L., De Gruijl F. R., Bergen Henegouwen J. B., Guikers K., Van Weelden H., Van Der Schans G. P., Baan R. A. Detection of photorepair of UV-induced thymine dimers in human epidermis by immunofluorescence microscopy. J Invest Dermatol. 1991 Jun;96(6):903–907. doi: 10.1111/1523-1747.ep12475429. [DOI] [PubMed] [Google Scholar]
  91. Santella R. M., Hemminki K., Tang D. L., Paik M., Ottman R., Young T. L., Savela K., Vodickova L., Dickey C., Whyatt R. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and urinary 1-hydroxypyrene in foundry workers. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):59–62. [PubMed] [Google Scholar]
  92. Santella R. M., Hsieh L. L., Lin C. D., Viet S., Weinstein I. B. Quantitation of exposure to benzo[a]pyrene with monoclonal antibodies. Environ Health Perspect. 1985 Oct;62:95–99. doi: 10.1289/ehp.856295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Santella R. M., Perera F. P., Young T. L., Zhang Y. J., Chiamprasert S., Tang D., Wang L. W., Beachman A., Lin J. H., DeLeo V. A. Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. Mutat Res. 1995 Apr;334(2):117–124. doi: 10.1016/0165-1161(95)90001-2. [DOI] [PubMed] [Google Scholar]
  94. Santella R. M., Weston A., Perera F. P., Trivers G. T., Harris C. C., Young T. L., Nguyen D., Lee B. M., Poirier M. C. Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA. Carcinogenesis. 1988 Jul;9(7):1265–1269. doi: 10.1093/carcin/9.7.1265. [DOI] [PubMed] [Google Scholar]
  95. Santella R. M., Yang X. Y., Hsieh L. L., Young T. L. Immunologic methods for the detection of carcinogen adducts in humans. Prog Clin Biol Res. 1990;340C:247–257. [PubMed] [Google Scholar]
  96. Savela K., Hemminki K. DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabelling assay. Carcinogenesis. 1991 Mar;12(3):503–508. doi: 10.1093/carcin/12.3.503. [DOI] [PubMed] [Google Scholar]
  97. Schoket B., Doty W. A., Vincze I., Strickland P. T., Ferri G. M., Assennato G., Poirier M. C. Increased sensitivity for determination of polycyclic aromatic hydrocarbon-DNA adducts in human DNA samples by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):349–353. [PubMed] [Google Scholar]
  98. Schoket B., Horkay I., Kósa A., Páldeák L., Hewer A., Grover P. L., Phillips D. H. Formation of DNA adducts in the skin of psoriasis patients, in human skin in organ culture, and in mouse skin and lung following topical application of coal-tar and juniper tar. J Invest Dermatol. 1990 Feb;94(2):241–246. doi: 10.1111/1523-1747.ep12874576. [DOI] [PubMed] [Google Scholar]
  99. Schoket B., Phillips D. H., Poirier M. C., Vincze I. DNA adducts in peripheral blood lymphocytes from aluminum production plant workers determined by 32P-postlabeling and enzyme-linked immunosorbent assay. Environ Health Perspect. 1993 Mar;99:307–309. doi: 10.1289/ehp.9399307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Shields P. G., Bowman E. D., Harrington A. M., Doan V. T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 1993 Aug 1;53(15):3486–3492. [PubMed] [Google Scholar]
  101. Shields P. G., Harris C. C., Petruzzelli S., Bowman E. D., Weston A. Standardization of the 32P-postlabeling assay for polycyclic aromatic hydrocarbon-DNA adducts. Mutagenesis. 1993 Mar;8(2):121–126. doi: 10.1093/mutage/8.2.121. [DOI] [PubMed] [Google Scholar]
  102. Shields P. G., Povey A. C., Wilson V. L., Weston A., Harris C. C. Combined high-performance liquid chromatography/32P-postlabeling assay of N7-methyldeoxyguanosine. Cancer Res. 1990 Oct 15;50(20):6580–6584. [PubMed] [Google Scholar]
  103. Shigenaga M. K., Gimeno C. J., Ames B. N. Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9697–9701. doi: 10.1073/pnas.86.24.9697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Shuker D. E. Nucleic acid-carcinogen adducts in human dosimetry. Arch Toxicol Suppl. 1989;13:55–65. doi: 10.1007/978-3-642-74117-3_6. [DOI] [PubMed] [Google Scholar]
  105. Shuker D. E., Prevost V., Friesen M. D., Lin D., Ohshima H., Bartsch H. Urinary markers for measuring exposure to endogenous and exogenous alkylating agents and precursors. Environ Health Perspect. 1993 Mar;99:33–37. doi: 10.1289/ehp.939933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Souliotis V. L., Kaila S., Boussiotis V. A., Pangalis G. A., Kyrtopoulos S. A. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Cancer Res. 1990 May 1;50(9):2759–2764. [PubMed] [Google Scholar]
  107. Spigelman A. D., Scates D. K., Venitt S., Phillips R. K. DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls. Carcinogenesis. 1991 Sep;12(9):1727–1732. doi: 10.1093/carcin/12.9.1727. [DOI] [PubMed] [Google Scholar]
  108. Stillwell W. G., Glogowski J., Xu H. X., Wishnok J. S., Zavala D., Montes G., Correa P., Tannenbaum S. R. Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine, and 7-methylguanine in a Colombian population at high risk for stomach cancer. Cancer Res. 1991 Jan 1;51(1):190–194. [PubMed] [Google Scholar]
  109. Strickland P. T., Boyle J. M. Immunoassay of carcinogen-modified DNA. Prog Nucleic Acid Res Mol Biol. 1984;31:1–58. doi: 10.1016/s0079-6603(08)60374-8. [DOI] [PubMed] [Google Scholar]
  110. Strickland P. T., Kang D., Bowman E. D., Fitzwilliam A., Downing T. E., Rothman N., Groopman J. D., Weston A. Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis. 1994 Mar;15(3):483–487. doi: 10.1093/carcin/15.3.483. [DOI] [PubMed] [Google Scholar]
  111. Talaska G., al-Juburi A. Z., Kadlubar F. F. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5350–5354. doi: 10.1073/pnas.88.12.5350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Terheggen P. M., Begg A. C., Emondt J. Y., Dubbelman R., Floot B. G., den Engelse L. Formation of interaction products of carboplatin with DNA in vitro and in cancer patients. Br J Cancer. 1991 Feb;63(2):195–200. doi: 10.1038/bjc.1991.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Terheggen P. M., Dijkman R., Begg A. C., Dubbelman R., Floot B. G., Hart A. A., den Engelse L. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients. Cancer Res. 1988 Oct 1;48(19):5597–5603. [PubMed] [Google Scholar]
  114. Umbenhauer D., Wild C. P., Montesano R., Saffhill R., Boyle J. M., Huh N., Kirstein U., Thomale J., Rajewsky M. F., Lu S. H. O(6)-methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int J Cancer. 1985 Dec 15;36(6):661–665. doi: 10.1002/ijc.2910360607. [DOI] [PubMed] [Google Scholar]
  115. Vahakangas K., Haugen A., Harris C. C. An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adducts. Carcinogenesis. 1985 Aug;6(8):1109–1115. doi: 10.1093/carcin/6.8.1109. [DOI] [PubMed] [Google Scholar]
  116. VanRooij J. G., Bodelier-Bade M. M., Hopmans P. M., Jongeneelen F. J. Reduction of urinary 1-hydroxypyrene excretion in coke-oven workers exposed to polycyclic aromatic hydrocarbons due to improved hygienic skin protective measures. Ann Occup Hyg. 1994 Jun;38(3):247–256. doi: 10.1093/annhyg/38.3.247-a. [DOI] [PubMed] [Google Scholar]
  117. Vodicka P., Vodicková L., Trejbalová K., Srám R. J., Hemminki K. Persistence of O6-guanine DNA adducts in styrene-exposed lamination workers determined by 32P-postlabelling. Carcinogenesis. 1994 Sep;15(9):1949–1953. doi: 10.1093/carcin/15.9.1949. [DOI] [PubMed] [Google Scholar]
  118. Watson W. P., Smith R. J., Huckle K. R., Wright A. S. Comparison of hydrocarbon--DNA adducts formed in mouse and human skin following treatment with benzo [A] pyrene. Arch Toxicol Suppl. 1987;11:93–98. doi: 10.1007/978-3-642-72558-6_13. [DOI] [PubMed] [Google Scholar]
  119. Weston A., Bowman E. D., Carr P., Rothman N., Strickland P. T. Detection of metabolites of polycyclic aromatic hydrocarbons in human urine. Carcinogenesis. 1993 May;14(5):1053–1055. doi: 10.1093/carcin/14.5.1053. [DOI] [PubMed] [Google Scholar]
  120. Weston A., Bowman E. D. Fluorescence detection of benzo[a]pyrene--DNA adducts in human lung. Carcinogenesis. 1991 Aug;12(8):1445–1449. doi: 10.1093/carcin/12.8.1445. [DOI] [PubMed] [Google Scholar]
  121. Weston A., Bowman E. D., Manchester D. K., Harris C. C. Fluorescence detection of lesions in DNA. Basic Life Sci. 1990;53:63–81. doi: 10.1007/978-1-4613-0637-5_5. [DOI] [PubMed] [Google Scholar]
  122. Weston A., Bowman E. D., Shields P. G., Trivers G. E., Poirier M. C., Santella R. M., Manchester D. K. Detection of polycyclic aromatic hydrocarbon-DNA adducts in human lung. Environ Health Perspect. 1993 Mar;99:257–259. doi: 10.1289/ehp.9399257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Weston A., Manchester D. K., Poirier M. C., Choi J. S., Trivers G. E., Mann D. L., Harris C. C. Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Chem Res Toxicol. 1989 Mar-Apr;2(2):104–108. doi: 10.1021/tx00008a006. [DOI] [PubMed] [Google Scholar]
  124. Weston A. Physical methods for the detection of carcinogen-DNA adducts in humans. Mutat Res. 1993 Jul;288(1):19–29. doi: 10.1016/0027-5107(93)90204-s. [DOI] [PubMed] [Google Scholar]
  125. Weston A., Rowe M. L., Manchester D. K., Farmer P. B., Mann D. L., Harris C. C. Fluorescence and mass spectral evidence for the formation of benzo[a]pyrene anti-diol-epoxide-DNA and -hemoglobin adducts in humans. Carcinogenesis. 1989 Feb;10(2):251–257. doi: 10.1093/carcin/10.2.251. [DOI] [PubMed] [Google Scholar]
  126. Wilson V. L., Basu A. K., Essigmann J. M., Smith R. A., Harris C. C. O6-alkyldeoxyguanosine detection by 32P-postlabeling and nucleotide chromatographic analysis. Cancer Res. 1988 Apr 15;48(8):2156–2161. [PubMed] [Google Scholar]
  127. Wilson V. L., Weston A., Manchester D. K., Trivers G. E., Roberts D. W., Kadlubar F. F., Wild C. P., Montesano R., Willey J. C., Mann D. L. Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcinogenesis. 1989 Nov;10(11):2149–2153. doi: 10.1093/carcin/10.11.2149. [DOI] [PubMed] [Google Scholar]
  128. Wogan G. N. Markers of exposure to carcinogens. Environ Health Perspect. 1989 May;81:9–17. doi: 10.1289/ehp.89819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Yang X. Y., DeLeo V., Santella R. M. Immunological detection and visualization of 8-methoxypsoralen-DNA photoadducts. Cancer Res. 1987 May 1;47(9):2451–2455. [PubMed] [Google Scholar]
  130. Yang X. Y., Gasparro F. P., DeLeo V. A., Santella R. M. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light. J Invest Dermatol. 1989 Jan;92(1):59–63. doi: 10.1111/1523-1747.ep13071224. [DOI] [PubMed] [Google Scholar]
  131. Yuspa S. H., Poirier M. C. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv Cancer Res. 1988;50:25–70. doi: 10.1016/s0065-230x(08)60434-0. [DOI] [PubMed] [Google Scholar]
  132. van Delft J. H., van den Ende A. M., Keizer H. J., Ouwerkerk J., Baan R. A. Determination of N7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazine. Carcinogenesis. 1992 Jul;13(7):1257–1259. doi: 10.1093/carcin/13.7.1257. [DOI] [PubMed] [Google Scholar]
  133. van Schooten F. J., Hillebrand M. J., van Leeuwen F. E., Lutgerink J. T., van Zandwijk N., Jansen H. M., Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. Carcinogenesis. 1990 Sep;11(9):1677–1681. doi: 10.1093/carcin/11.9.1677. [DOI] [PubMed] [Google Scholar]
  134. van Schooten F. J., van Leeuwen F. E., Hillebrand M. J., de Rijke M. E., Hart A. A., van Veen H. G., Oosterink S., Kriek E. Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J Natl Cancer Inst. 1990 Jun 6;82(11):927–933. doi: 10.1093/jnci/82.11.927. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES